Unknown

Dataset Information

0

N-Acylbenzenesulfonamide Dihydro-1,3,4-oxadiazole Hybrids: Seeking Selectivity toward Carbonic Anhydrase Isoforms.

ABSTRACT: A series of N-acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids (EMAC8000a-m) was designed and synthesized with the aim to target tumor associated carbonic anhydrase (hCA) isoforms IX and XII. Most of the compounds were selective inhibitors of the tumor associated hCA XII. Moreover, resolution of EMAC8000d racemic mixture led to the isolation of the levorotatory eutomer exhibiting an increase of hCA XII inhibition potency and selectivity with respect to hCA II. Computational studies corroborated these data. Overall our data indicate that both substitution pattern and stereochemistry of dihydro-1,3,4-oxadiazole could be considered as key factors to determine activity and selectivity toward hCA isozymes. These results can provide further indication for the design and optimization of selective hCA inhibitors.

SUBMITTER: Bianco G 

PROVIDER: S-EPMC5554910 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

<i>N</i>-Acylbenzenesulfonamide Dihydro-1,3,4-oxadiazole Hybrids: Seeking Selectivity toward Carbonic Anhydrase Isoforms.

Bianco Giulia G   Meleddu Rita R   Distinto Simona S   Cottiglia Filippo F   Gaspari Marco M   Melis Claudia C   Corona Angela A   Angius Rossella R   Angeli Andrea A   Taverna Domenico D   Alcaro Stefano S   Leitans Janis J   Kazaks Andris A   Tars Kaspars K   Supuran Claudiu T CT   Maccioni Elias E  

ACS medicinal chemistry letters 20170621 8

A series of <i>N</i>-acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids (<b>EMAC8000a-m</b>) was designed and synthesized with the aim to target tumor associated carbonic anhydrase (hCA) isoforms IX and XII. Most of the compounds were selective inhibitors of the tumor associated hCA XII. Moreover, resolution of <b>EMAC8000d</b> racemic mixture led to the isolation of the levorotatory eutomer exhibiting an increase of hCA XII inhibition potency and selectivity with respect to hCA II. Computa  ...[more]

Similar Datasets

Unknown New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII.
| S-EPMC7236253 | biostudies-literature
Unknown Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms.
| S-EPMC7236538 | biostudies-literature
Unknown The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX.
| S-EPMC7534198 | biostudies-literature
Unknown Glycomimetic Based Approach toward Selective Carbonic Anhydrase Inhibitors.
| S-EPMC7236246 | biostudies-literature
Unknown Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors.
| S-EPMC6968703 | biostudies-literature
Unknown Probing the chemical interaction space governed by 4-aminosubstituted benzenesulfonamides and carbonic anhydrase isoforms.
| S-EPMC5921400 | biostudies-literature
Unknown Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies.
| S-EPMC9090362 | biostudies-literature
Unknown Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations.
| S-EPMC2950089 | biostudies-literature
Transcriptomics carbonic anhydrase (1 or 2) simple or double mutants-Comparative transcriptome analysis between carbonic anhydrase mutants and wild type Arabidopsis
2012-03-25 | GSE36625 | GEO
Unknown Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV<sup>600E</sup>.
| S-EPMC10504751 | biostudies-literature